These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 15017388)
1. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells. Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388 [TBL] [Abstract][Full Text] [Related]
2. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression. Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760 [TBL] [Abstract][Full Text] [Related]
3. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines. Wang XW; Xu YH Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis and modeling of glucocorticoid-controlled gene expression. Chen DW; Lynch JT; Demonacos C; Krstic-Demonacos M; Schwartz JM Pharmacogenomics; 2010 Nov; 11(11):1545-60. PubMed ID: 21121775 [TBL] [Abstract][Full Text] [Related]
5. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance. Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271 [TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines. Hala M; Hartmann BL; Böck G; Geley S; Kofler R Int J Cancer; 1996 Nov; 68(5):663-8. PubMed ID: 8938150 [TBL] [Abstract][Full Text] [Related]
7. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988 [TBL] [Abstract][Full Text] [Related]
8. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor. Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130 [TBL] [Abstract][Full Text] [Related]
9. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Strasser-Wozak EM; Hattmannstorfer R; Hála M; Hartmann BL; Fiegl M; Geley S; Kofler R Cancer Res; 1995 Jan; 55(2):348-53. PubMed ID: 7812967 [TBL] [Abstract][Full Text] [Related]
10. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Medh RD; Saeed MF; Johnson BH; Thompson EB Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879 [TBL] [Abstract][Full Text] [Related]
11. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230 [TBL] [Abstract][Full Text] [Related]
12. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741 [TBL] [Abstract][Full Text] [Related]
14. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. Russcher H; Smit P; van den Akker EL; van Rossum EF; Brinkmann AO; de Jong FH; Lamberts SW; Koper JW J Clin Endocrinol Metab; 2005 Oct; 90(10):5804-10. PubMed ID: 16030164 [TBL] [Abstract][Full Text] [Related]
15. Changes of glucocorticoid receptor isoforms expression in acute lymphoblastic leukemia correlate with glucocorticoid resistance. Sun X; Fang M; Guan Y; Si Y; Ma L; Wang Y; Jia Z Pharmazie; 2015 May; 70(5):316-21. PubMed ID: 26062300 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor. Schmidt S; Irving JA; Minto L; Matheson E; Nicholson L; Ploner A; Parson W; Kofler A; Amort M; Erdel M; Hall A; Kofler R FASEB J; 2006 Dec; 20(14):2600-2. PubMed ID: 17077285 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis. Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1. Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608 [TBL] [Abstract][Full Text] [Related]
19. Yellow fluorescent protein-tagged and cyan fluorescent protein-tagged imaging analysis of glucocorticoid receptor and importins in single living cells. Tanaka M; Nishi M; Morimoto M; Sugimoto T; Kawata M Endocrinology; 2003 Sep; 144(9):4070-9. PubMed ID: 12933681 [TBL] [Abstract][Full Text] [Related]
20. Low glucocorticoid receptor (GR), high Dig2 and low Bcl-2 expression in double positive thymocytes of BALB/c mice indicates their endogenous glucocorticoid hormone exposure. Boldizsár F; Pálinkás L; Czömpöly T; Bartis D; Németh P; Berki T Immunobiology; 2006; 211(10):785-96. PubMed ID: 17113916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]